XANTIUM Trademark

Trademark Overview

On Monday, July 6, 2026, a trademark application was filed for XANTIUM with the United States Patent and Trademark Office. The USPTO has given the XANTIUM trademark a serial number of 99923620. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, July 6, 2026. This trademark is owned by Xantium Rx Inc.. The XANTIUM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of autoimmunological, bacterial, cardiovascular, central and peripheral nervous system, diabetic, endocrine, haematological, hormonal, gastrointestinal, gout, immunological, infectious, inflammation and inflammatory, musculoskeletal, neurological, oncological, pain, respiratory, urological and viral diseases and disorders; Vaccines
xantium

General Information

Serial Number99923620
Word MarkXANTIUM
Filing DateMonday, July 6, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateMonday, July 6, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkXANTHIUM
Goods and ServicesPharmaceutical preparations for the treatment and prevention of autoimmunological, bacterial, cardiovascular, central and peripheral nervous system, diabetic, endocrine, haematological, hormonal, gastrointestinal, gout, immunological, infectious, inflammation and inflammatory, musculoskeletal, neurological, oncological, pain, respiratory, urological and viral diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 6, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameXantium Rx Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08540
US

Trademark Events

Event DateEvent Description
Monday, July 6, 2026NEW APPLICATION ENTERED
Monday, July 6, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 6, 2026APPLICATION FILING RECEIPT MAILED

Related Keywords

xantium musculoskeletal neurological inflammatory inflammation immunological infectious oncological pain disorders vaccines